HROW Insider Trading

Insider Ownership Percentage: 13.67%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $0.00

Harrow Insider Trading History Chart

This chart shows the insider buying and selling history at Harrow by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$0soldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2-$1M-$500k$0$500k$1MTotal Insider BuyingTotal Insider Selling

Harrow Share Price & Price History

Current Price: $24.67
Price Change: Price Increase of +0.02 (0.08%)
As of 04/29/2025 05:00 PM ET

This chart shows the closing price history over time for HROW up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
JunJulAugSepOctNovDecJanFebMarApr$24.65Closing price on 04/28/25:

SEC Filings (Institutional Ownership Changes) for Harrow (NASDAQ:HROW)

72.76% of Harrow stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at HROW by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table
2022202320242025$2.18Mbought$2.64MsoldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2-$40M-$20M$0$20M$40MTotal InflowsTotal Outflows
Harrow logo
Harrow, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business. The company was formerly known as Imprimis Pharmaceuticals, Inc. and changed its name to Harrow Health, Inc. in December 2018. Harrow Health, Inc. was incorporated in 2006 and is headquartered in Nashville, Tennessee.
Read More on Harrow

Today's Range

Now: $24.67
Low: $24.22
High: $25.37

50 Day Range

MA: $25.36
Low: $22.20
High: $30.13

52 Week Range

Now: $24.67
Low: $10.04
High: $59.23

Volume

258,569 shs

Average Volume

502,822 shs

Market Capitalization

$879.58 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.46

Who are the company insiders with the largest holdings of Harrow?

Harrow's top insider shareholders include:
  1. Opaleye Management Inc (Major Shareholder)
  2. Mark L Baum (CEO)
  3. Martin A Makary (Director)
Learn More about top insider investors at Harrow.

Who are the major institutional investors of Harrow?

Harrow's top institutional shareholders include:
  1. Westside Investment Management Inc. — 0.49%
  2. Woodmont Investment Counsel LLC — 0.29%
  3. D.A. Davidson & CO. — 0.17%
  4. IMC Chicago LLC — 0.00%
  5. Rhumbline Advisers — 0.12%
  6. SG Americas Securities LLC — 0.08%
Learn More about top institutional investors of Harrow stock.

Which institutional investors are selling Harrow stock?

In the last quarter, HROW stock was sold by these institutional investors:
  1. Assenagon Asset Management S.A.
  2. SG Americas Securities LLC
  3. D.A. Davidson & CO.
  4. Teacher Retirement System of Texas

Which institutional investors are buying Harrow stock?

In the last quarter, HROW stock was acquired by institutional investors including:
  1. IMC Chicago LLC
  2. Woodmont Investment Counsel LLC
  3. Westside Investment Management Inc.
  4. GAMMA Investing LLC
  5. Rhumbline Advisers
Within the last year, these company insiders have bought Harrow stock:
  1. Opaleye Management Inc (Major Shareholder)
  2. Mark L Baum (CEO)
  3. Martin A Makary (Director)
Learn More investors buying Harrow stock.